Clinical Trials Directory

Trials / Sponsors / 3D Medicines (Sichuan) Co., Ltd.

3D Medicines (Sichuan) Co., Ltd.

Industry · 11 registered clinical trials — 6 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingMulticenter Phase 2 Study of Envafolimab in Biliary Tract Cancers
Biliary Tract Neoplasms
Phase 22027-06-01
RecruitingPhase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC
Non-small Cell Lung Cancer
Phase 32023-11-17
CompletedPhase I Trial of Envafolimab for Healthy Male Subjects
Healthy Male
Phase 12023-05-29
RecruitingStudy of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
Advanced Endometrial Cancer
Phase 22022-03-04
RecruitingPhase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma
Phase 1 / Phase 22021-11-15
RecruitingENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
Solid Tumor
Phase 22021-08-06
RecruitingKN035 for dMMR/MSI-H Advanced Solid Tumors
Solid Tumor
Phase 22018-08-22
Active Not RecruitingProgrammed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC
Biliary Tract Neoplasms
Phase 32018-04-16
CompletedA Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors
Advanced or Metastatic Solid Tumors
Phase 12017-09-15
CompletedPhase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors
Solid Tumors
Phase 12017-03-21
CompletedPhase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors
Solid Tumors
Phase 12017-01-13